Molecular Diagnostics
Biodesix’s MRD Test for Solid Tumors to Run on Bio-Rad's Upcoming QX600 ddPCR System
Biodesix, Inc. (Boulder, CO, USA) is developing a new novel minimal residual disease (MRD) test in association with the Memorial Sloan Kettering Cancer Center (MSK, New York, NY, USA) that will utilize the advanced multiplexing QX600 ddPCR System to be launched by Bio-Rad Laboratories (Hercules, CA, USA) later this year. More...07 Jun 2022
Blood Test Enables Early Detection of Oral Cancer
Researchers have used a technology called conductive polymer spray ionization mass spectrometry to screen the blood for metabolic signs of oral squamous cell carcinoma (OSCC) - a type of cancer of the mouth and throat - that contributes around 90% of oral cancers. More...07 Jun 2022
MIS-C Linked to Rare, Immune-Related Variants
Multisystem inflammatory syndrome in children (MIS-C) is a critical and potentially life-threatening complication of COVID-19 in pediatric settings. Children who were diagnosed with MIS-C tested positive for SARS-CoV-2 infection by reverse transcriptase–polymerase chain reaction (RT-PCR) or antibody testing and had fever for more than four days. More...07 Jun 2022
Noninvasive Blood Test Predicts Rejection After Heart Transplant
Heart transplantation (HTx) is the definitive treatment option for patients with advanced heart failure. Despite continued advances in post-transplant outcomes, allograft rejection and allograft injury remain impediments to post-transplant survival. More...06 Jun 2022
Proteomics-based Blood Test May Replace Biopsy for Diagnosis of Liver Disease
A mass spectroscopy-based proteomics assay was able to predict whether an individual subject was afflicted by alcohol-related liver disease and whether the individual was at risk of disease progression. More...06 Jun 2022
Gold Member
Hybrid Pipette
SWITCH
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
 (3) (1).png){kind=logo}
Pipette
Accumax Smart Series
8-Channel Pipette
SAPPHIRE 20–300 µL
In Other News
Testing for DNA Shed from Colon Cancers into Bloodstream Guides Chemotherapy After Surgery
Blood Test May Be a Game-Changer for TB Diagnoses and Treatment
Blood Test Detects and Monitors Cell Death to Predict Disease Severity
Non-Invasive Tests for Diagnosing Liver Diseases Could Shape Future Clinical Care
Results of Alzheimer’s Disease Blood Tests Are Skewed by Unrelated Chronic Conditions
Liquid Biopsy Predicts Success of ICI Treatment in Lung Cancer Patients
Lung Cancer Detection Blood Test to Reduce Need for Repeated CT Scanning
Molecular Profiling Identifies High-Risk Subtype of Pediatric Liver Cancer
Roche Develops Monkeypox Virus Detection PCR Tests
POC Critical Illness Test Designed for Early Warning and Patient Triaging
World’s First Biomarker Can Diagnose Parkinson's Disease from Blood Serum Samples
Tear Fluid Collected Using Noninvasive Technique Could Help Diagnose Diseases
Illumina’s Pan-Cancer Companion Diagnostic Enables Targeted Therapy
LumiraDx HbA1c Assay Screens and Identifies Patients at Risk for Developing Diabetes
POC System Could Transform Infectious Disease Management
mRNA Test Screens for Multiple Cancers from Single Blood Sample
A Circulating Antibody Enables Prediction of Crohn’s Disease Long Before Symptoms Appear
Bioperfectus Monkeypox Virus Real Time PCR Kit Receives CE Mark
Blood Test Detects Markers for Liver Injury from Acetaminophen Overdose in 20 Minutes
Next-Generation Sequencing Enables Diagnosis of Primary Immunodeficiency Disorders
Clinical Multiplex Benchtop Diagnostic System Runs Tests Directly From Whole Blood
Blood Test Predicts Response to Immunotherapy in Patients with Non-Small Cell Lung Cancer
ALL Genomes Marked by High DNA Methylation Levels
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
